Patent USRE31463E successfully refreshed from Google Patents.
← Back to Patent Explorer
USRE31463E Expired / Lapsed US ⏱️ 0.0 years remaining

Radiopharmaceutical chelates and method of external imaging

Assignee: Research Corp
•
Filing: 1980-05-08
•
Granted: 1983-12-13
•
Expires: 2000-05-08
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A chelate of technetium-99m, cobalt-57, gallium-67, gallium-68, indium-111 or indium-113m and substituted iminodiacetic acid or an 8-hydroxyquinoline useful as a radiopharmaceutical external imaging agent. The invention also includes preparative methods therefor.

Inventors

  • 👤 Michael D. Loberg
  • 👤 Patrick S. Callery
  • 👤 Malcolm Cooper

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 23:26
CPC Classifications
A; A61; A61K; A61K51/00; A61K51/02; A61K51/04; A61K2123/00

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 39 words
A chelate of technetium-99m, cobalt-57, gallium-67, gallium-68, indium-111 or indium-113m and a substituted iminodiacetic acid .[...]..Iadd., said chelate, upon intravenous administration, being liver and/or gallbladder selective..Iaddend. .[.2. A chelate of technetium-99m cobalt-57, gallium-67, gallium-68, indium-111 or indium-113m and an
Claim 2
Dependent Claim 39 words
A chelate of technetium-99m, cobalt-57, gallium-67, gallium-68, indium-111 or indium-113m and a substituted iminodiacetic acid .[...]..Iadd., said chelate, upon intravenous administration, being liver and/or gallbladder selective..Iaddend. .[.2. A chelate of technetium-99m cobalt-57, gallium-67, gallium-68, indium-111 or indium-113m and an
Claim 3
Dependent Claim 20 words
8-hydroxyquinoline..]. 3. A composition comprising a mixture of the technetium-99m chelate of claim 1 and the stannous chelate of said
Claim 4
Dependent Claim 21 words
chelating agent. 4. A composition comprising a mixture of the technetium-99m chelate of claim 1, the stannous chelate of said chelating
Claim 5
Dependent Claim 33 words
agent and said chelating agent. 5. The chelate of claim 1 wherein said iminodiacetic acid chelating agent is N-methyliminodiacetic acid, N-[N'-(2,6-dimethylphenyl) carbamoylmethyl] iminodiacetic acid, N-(10-carboxydecyl) iminodiacetic acid, N-(O-bromobenzyl) iminodiacetic acid, N-[3-(1-naphthyloxy)-2-hydroxypropyl] iminodiacetic acid,
Claim 6
Dependent Claim 5 words
.[.nitrilo-triacetic acid.]. or 2,6-pyridinedicarboxylic acid.
Claim 7
Dependent Claim 5 words
.[.nitrilo-triacetic acid.]. or 2,6-pyridinedicarboxylic acid.
Claim 8
Dependent Claim 45 words
N-[N'(2,6-dimethylphenyl) carbamoylmethyl] iminodiacetic acid. 7. A method of external imaging which includes the intravenous administration of a solution adapted for intravenous administration containing the chelate of claim 1. .[.8. A method of external imaging which includes the intravenous administration of a solution adapted for intravenous
Claim 9
Dependent Claim 21 words
administration containing the chelate of claim 2..]. 9. A method of preparing the chelate of claim 1 comprising reacting said radio-isotope
Claim 10
Dependent Claim 12 words
with said chelating agent. 10. The method of claim 9 wherein said
Claim 11
Dependent Claim 23 words
radioisotope is technetium-99m. 11. The method of claim 10 wherein said chelate is prepared by reducing a pertechnetrate in the presence of said
Claim 12
Dependent Claim 131 words
chelating agent. 12. The method of claim 11 wherein said reduction is effected utilizing stannous chloride as a reducing agent. .[.13. A method of preparing the chelate of claim 2 comprising reacting said radio-isotope with said chelating agent..]..Iadd. 14. A chelate of technetium-99m, cobalt-57, gallium-67, gallium-68, indium-111 or indium-113m and 5,7-diiodo-8-hydroxyquinoline. .Iaddend..Iadd. 15. A method of external imaging which includes the intravenous administration of a solution adapted for intravenous administration and containing the chelate of claim 14. .Iaddend..Iadd. 16. A method of preparing the chelate of claim 14 comprising reacting said radio-isotope with said chelating agent. .Iaddend. .Iadd. 17. A chelate of technetium-99m, cobalt-57, gallium-67, gallium-68, indium-111 or indium-113m and a substituted iminodiacetic acid of the formula: .Iaddend. ##STR2## .Iadd.wherein R may be alkyl having up to 14 carbon atoms. .Iaddend..Iadd.
Claim 13
Dependent Claim 182 words
A composition comprising a mixture of the technetium-99m chelate of claim 17 and the stannous chelate of said chelating agent. .Iaddend..Iadd. 19. A composition comprising a mixture of the technetium-99m chelate of claim 17, the stannous chelate of said chelating agent and said chelating agent. .Iaddend..Iadd. 20. A method of external imaging which includes the intravenous administration of a solution adapted for intravenous administration containing the chelate of claim 17. .Iaddend..Iadd. 21. A method of preparing the chelate of claim 17 comprising reacting said radio-isotope with said chelating agent. .Iaddend. .Iadd. 22. A chelate of technetium-99m, cobalt-57, gallium-67, gallium-68, indium-111 or indium-113m and N-[N'-(2,6-dimethylphenyl) carbamoylmethyl] iminodiacetic acid. .Iaddend. .Iadd. 23. A chelate of technetium-99m, cobalt-57, gallium-67, gallium-68, indium-111 or indium-113m and methyliminodiacetic acid. .Iaddend..Iadd. 24. A chelate of technetium-99m, cobalt-57, gallium-67, gallium-68, indium-111 or indium-113m and 10-carboxydecyliminodiacetic acid. .Iaddend..Iadd. 25. A chelate of technetium-99m, cobalt-57, galium-67, gallium-68, indium-111 or indium-113m and N-(o-bromobenzyl) iminodiacetic acid. .Iaddend..Iadd. 26. A chelate of technetium-99m, cobalt-57, gallium-67, gallium-68, indium-111 or indium-113m and 2,6-pyridinedicarboxylic acid. .Iaddend..Iadd. 27. A chelate of claim 1 wherein said radioisotope is technetium-99m. .Iaddend.

References Cited (Backward Citations)

US2886568A Cited
US3560508A Cited
US3466361A Cited
US3728351A Cited
US3725295A Cited
US4065455A Cited
US4088747A Cited
US4091088A Cited
SU598884A1 Cited
US4256726A Cited
JPS557252A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-12-12 1987-06-13 1987-12-13 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-12-12 1991-06-13 1991-12-13 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-12-12 1995-06-13 1995-12-13 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag